Baxter International (BAX) Asset Writedowns and Impairment (2010 - 2025)

Baxter International (BAX) has reported Asset Writedowns and Impairment for 8 consecutive years, with $290.0 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Asset Writedowns and Impairment rose 3525.0% year-over-year to $290.0 million; the TTM figure through Jun 2026 stood at $290.0 million (down 3.01% YoY), while the FY2025 annual figure was $290.0 million, up 480.0% from the prior year.
• Asset Writedowns and Impairment improved to $290.0 million in Q4 2025 per BAX's latest filing, from $2.0 million in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $290.0 million in Q4 2025 and bottomed at -$332.0 million in Q3 2022.
• Historically, Asset Writedowns and Impairment has averaged $84.9 million across 5 years, with a median of $17.0 million in 2022.
• Annual changes were most pronounced in 2023 — Asset Writedowns and Impairment slumped 216.67% — and 2025, when it soared 3525.0%.
• Baxter International's Asset Writedowns and Impairment stood at $11.0 million in 2021, then increased by 9.09% to $12.0 million in 2022, then plunged by 216.67% to -$14.0 million in 2023, then surged by 157.14% to $8.0 million in 2024, then jumped by 3525.0% to $290.0 million in 2025.
• Business Quant data shows BAX's Asset Writedowns and Impairment at $290.0 million in Q4 2025, $2.0 million in Q2 2025, and $22.0 million in Q1 2025.